Serina Therapeutics, Inc.
General ticker "SER" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $39.7M (TTM average)
Serina Therapeutics, Inc. does not follow the US Stock Market performance with the rate: -21.1%.
Estimated limits based on current volatility of 4.5%: low 2.59$, high 2.84$
Factors to consider:
- Total employees count: 16 (+23.1%) as of 2025
- US accounted for 63.4% of revenue in the fiscal year ended 2023-12-31
- Top business risk factors: Operating losses, Clinical trial success, Regulatory and compliance, Manufacturing risks, Market competition
- Price in estimated range
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.65$, 4.88$]
- 2026-12-31 to 2027-12-31 estimated range: [1.52$, 4.40$]
Financial Metrics affecting the SER estimates:
- Positive: with PPE of -1.2 at the end of fiscal year the price was neutral
- Negative: Operating cash flow per share per price, % of -74.80 <= 0.30
- Negative: negative Operating income
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: negative Net income
- Positive: Investing cash flow per share per price, % of -0.25 > -0.65
Short-term SER quotes
Long-term SER plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.21MM | $0.06MM | $0.00MM |
| Operating Expenses | $10.10MM | $17.10MM | $24.02MM |
| Operating Income | $-9.89MM | $-17.05MM | $-24.02MM |
| Non-Operating Income | $-4.92MM | $5.84MM | $4.83MM |
| Interest Expense | $4.90MM | $0.53MM | $0.21MM |
| R&D Expense | $0.73MM | $7.48MM | $13.15MM |
| Income(Loss) | $-14.81MM | $-11.21MM | $-19.20MM |
| Taxes | $0.00MM | $0.00MM | $0.02MM |
| Net Income(Loss)* | $-14.80MM | $-11.14MM | $-19.44MM |
| Stockholders Equity | $-32.29MM | $0.64MM | $-0.04MM |
| Assets | $8.97MM | $6.72MM | $6.95MM |
| Operating Cash Flow | $-2.48MM | $-17.14MM | $-17.95MM |
| Capital expenditure | $0.50MM | $0.02MM | $0.06MM |
| Investing Cash Flow | $-0.50MM | $-0.02MM | $-0.06MM |
| Financing Cash Flow | $10.07MM | $13.21MM | $17.41MM |
| Earnings Per Share** | $-1.76 | $-1.51 | $-1.91 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.